Mark C. Mochel

1.0k total citations
39 papers, 663 citations indexed

About

Mark C. Mochel is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Mark C. Mochel has authored 39 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Mark C. Mochel's work include Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (6 papers) and Cancer and Skin Lesions (6 papers). Mark C. Mochel is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (6 papers) and Cancer and Skin Lesions (6 papers). Mark C. Mochel collaborates with scholars based in United States, Portugal and Taiwan. Mark C. Mochel's co-authors include Mai P. Hoang, Adriano Piris, Dora Dias‐Santagata, David N. Louis, Chakib Boussahmain, Kerry D. Lynch, Daniela Kroshinsky, Guilin Wang, Stefan Kraft and Lyn M. Duncan and has published in prestigious journals such as Advanced Materials, Blood and The American Journal of Medicine.

In The Last Decade

Mark C. Mochel

36 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Mochel United States 13 231 174 127 101 97 39 663
Takuya Miyagawa Japan 13 171 0.7× 127 0.7× 59 0.5× 118 1.2× 85 0.9× 57 660
Syed M. Gilani United States 12 144 0.6× 151 0.9× 164 1.3× 84 0.8× 25 0.3× 49 578
A. Cantagrel France 20 133 0.6× 241 1.4× 150 1.2× 169 1.7× 30 0.3× 57 1.2k
Fernando Chahud Brazil 13 110 0.5× 139 0.8× 98 0.8× 127 1.3× 75 0.8× 96 621
Hsiang‐Lin Song Taiwan 14 96 0.4× 104 0.6× 76 0.6× 88 0.9× 44 0.5× 27 590
Claudio Corallo Italy 15 36 0.2× 228 1.3× 93 0.7× 173 1.7× 83 0.9× 32 770
Xingchen Li China 15 174 0.8× 295 1.7× 153 1.2× 66 0.7× 17 0.2× 76 851
Elizabeth Mercer United States 13 284 1.2× 277 1.6× 90 0.7× 84 0.8× 13 0.1× 20 1.0k
Shyam S. Raghavan United States 18 291 1.3× 191 1.1× 252 2.0× 84 0.8× 94 1.0× 50 872

Countries citing papers authored by Mark C. Mochel

Since Specialization
Citations

This map shows the geographic impact of Mark C. Mochel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Mochel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Mochel more than expected).

Fields of papers citing papers by Mark C. Mochel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Mochel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Mochel. The network helps show where Mark C. Mochel may publish in the future.

Co-authorship network of co-authors of Mark C. Mochel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Mochel. A scholar is included among the top collaborators of Mark C. Mochel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Mochel. Mark C. Mochel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turner, Scott A., et al.. (2024). Cutaneous Rosai–Dorfman disease with MAP2K1 mutation, initially mimicking an infection with parasitized histiocytes. Journal of Cutaneous Pathology. 51(12). 942–947. 1 indexed citations
2.
Mochel, Mark C., et al.. (2024). Enfortumab vedotin‐induced cutaneous eruption: Ring mitotic figures as a distinctive histopathologic feature. Journal of Cutaneous Pathology. 51(11). 847–851. 4 indexed citations
3.
Maji, Santanu, Amit Kumar, Praveen Bhoopathi, et al.. (2023). Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Molecular Cancer Therapeutics. 22(10). 1115–1127. 4 indexed citations
4.
Nutan, Nutan, et al.. (2023). Disseminated Xanthogranuloma with BRAF Gene Fusion and Profound Response to MEK Inhibitor Therapy. Blood. 142(Supplement 1). 6429–6429.
5.
Mochel, Mark C., et al.. (2022). Nivolumab-Induced de novo Discoid Lupus Erythematosus. Case Reports in Dermatology. 14(1). 88–92. 7 indexed citations
6.
Donizy, Piotr, Joanna Wróblewska, Dora Dias‐Santagata, et al.. (2021). Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles. Cancers. 13(7). 1621–1621. 12 indexed citations
7.
Zhu, Xiaoqin, Jian Zou, Venu Bathini, et al.. (2021). Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status. Modern Pathology. 34(5). 1017–1030. 21 indexed citations
8.
Jackson‐Cook, Colleen, et al.. (2020). A Reappraisal of Superficial Pleomorphic Liposarcoma. American Journal of Clinical Pathology. 154(3). 353–361. 4 indexed citations
9.
Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations. Modern Pathology. 33(12). 2397–2406. 20 indexed citations
10.
Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles. Modern Pathology. 33(8). 1466–1474. 32 indexed citations
11.
Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma. Modern Pathology. 33(12). 2614–2625. 9 indexed citations
12.
Williams, Erik A., Meagan Montesion, Brian M. Alexander, et al.. (2020). CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features. Modern Pathology. 34(2). 358–370. 12 indexed citations
13.
Bryson, Alexandra, et al.. (2020). Diffuse Skin Nodules in an Oyster Farmer: Disseminated Mycobacterium marinum. The American Journal of Medicine. 134(1). e57–e59. 5 indexed citations
14.
Mochel, Mark C., et al.. (2020). Metastasizing basal cell carcinoma: A clinicopathologic and immunohistochemical study of 22 cases. Journal of Cutaneous Pathology. 48(3). 374–383. 6 indexed citations
15.
Mochel, Mark C., et al.. (2018). Mesenchymal Neoplasms of the Genitourinary System. Surgical pathology clinics. 11(4). 837–876. 3 indexed citations
16.
Mochel, Mark C., Marc R. Hammond, Dennie T. Frederick, et al.. (2015). Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients. Journal of the American Academy of Dermatology. 73(3). 491–499.e2. 8 indexed citations
17.
Mochel, Mark C., Lyn M. Duncan, Adriano Piris, & Stefan Kraft. (2014). Primary Mucosal Melanoma of the Sinonasal Tract: A Clinicopathologic and Immunohistochemical Study of Thirty-Two Cases. Head and Neck Pathology. 9(2). 236–243. 26 indexed citations
18.
Mochel, Mark C., et al.. (2013). Cutaneous Calciphylaxis. American Journal of Dermatopathology. 35(5). 582–586. 76 indexed citations
19.
Boussahmain, Chakib, Mark C. Mochel, & Mai P. Hoang. (2013). Perilipin and adipophilin expression in sebaceous carcinoma and mimics. Human Pathology. 44(9). 1811–1816. 35 indexed citations
20.
Pereira, Maria, Ben Ouyang, Cathryn A. Sundback, et al.. (2012). A Highly Tunable Biocompatible and Multifunctional Biodegradable Elastomer. Advanced Materials. 25(8). 1209–1215. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuya Miyagawa Breakdown of academic impact, for papers by Syed M. Gilani Breakdown of academic impact, for papers by A. Cantagrel Breakdown of academic impact, for papers by Fernando Chahud Breakdown of academic impact, for papers by Hsiang‐Lin Song Breakdown of academic impact, for papers by Claudio Corallo Breakdown of academic impact, for papers by Xingchen Li Breakdown of academic impact, for papers by Elizabeth Mercer Breakdown of academic impact, for papers by Shyam S. Raghavan
Rankless by CCL
2026